<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531881</url>
  </required_header>
  <id_info>
    <org_study_id>I 66805</org_study_id>
    <nct_id>NCT01531881</nct_id>
  </id_info>
  <brief_title>Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression</brief_title>
  <official_title>Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research may help dentists or surgeons to better detect areas in the mouth that are
      either prone to cancer or are early cancers. The earlier the detection on cancer in the
      mouth, the better the chance that treatment or prevention can be more effective.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>to investigate whether the use of a fluorescent light in the mouth can detect precancers or early cancers that are not seen on normal clinical examination.</measure>
    <time_frame>Once at time of consent (day 1)</time_frame>
    <description>The first purpose of this activity is to investigate whether the use of a fluorescent light in the mouth can detect precancers or early cancers that are not seen on normal clinical examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The second purpose is to collect other samples from the mouth in hopes to identify changes in the proteins and/or genes that will help identify how cancers start in the mouth.</measure>
    <time_frame>Once at time of consent (day 1)</time_frame>
    <description>The second purpose is to collect other samples from the mouth in hopes to identify changes in the proteins and/or genes that will help identify how cancers start in the mouth.</description>
  </secondary_outcome>
  <enrollment type="Actual">240</enrollment>
  <condition>Oral Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva, oral mucosal and tongue brushings.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Dental clinic patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with a history of suspicious lesions or currant suspicious lesions:

          -  No history of CIS or HNSCC

          -  History of clinically suspicious oral/oral pharyngeal lesions.

          -  Over 21 years old

          -  Not actively under treatment for any other type of malignancy, except Non-Melanoma
             Skin Cancer (NMSC)

          -  Must be willing to sign consent, have AFL screening with biopsies and sample
             collection, must be willing to complete a social and health history questionnaire

        Patients with biopsy proven dysplasia, CIS or HNSCC prior to treatment:

          -  Patients with biopsy proven dysplasia, CIS or HNSCC without a prior history of an
             antineoplastic treatment, including chemo/radiation and Photodynamic Therapy

          -  Biopsy performed at an outside institution and referred for evaluation for treatment,
             or biopsied here at RPCI and proceeding for further care.

          -  Over 21 years of age.

          -  Must be willing to sign consent, have AFL screening with biopsies and sample
             collection, must be willing to complete a social and health history questionnaire

        Patients with clinically treated CIS or HNSCC amd no evidence of disease (NED):

          -  Patients with prior history of HNSCC, previously treated with either surgery alone or
             combination of therapy, including Head and Neck radiation, with or without
             chemotherapy and Photodynamic Therapy including at least 3 months following completion
             of definitive treatment.

          -  Over 21 years of age

          -  Must be willing to sign consent, have AFL screening with biopsies and sample
             collection, must be willing to complete a social and health history questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Reid, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2012</study_first_submitted>
  <study_first_submitted_qc>February 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2012</study_first_posted>
  <last_update_submitted>January 5, 2018</last_update_submitted>
  <last_update_submitted_qc>January 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

